Chevy Chase Trust Holdings, Inc. Moderna, Inc. Transaction History
Chevy Chase Trust Holdings, Inc.
- $31.1 Billion
- Q2 2024
A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 182,644 shares of MRNA stock, worth $12 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
182,644
Previous 184,291
0.89%
Holding current value
$12 Million
Previous $19.6 Million
10.44%
% of portfolio
0.07%
Previous 0.06%
Shares
13 transactions
Others Institutions Holding MRNA
# of Institutions
1,113Shares Held
241MCall Options Held
9.26MPut Options Held
12.1M-
Baillie Gifford & CO43.4MShares$2.86 Billion4.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$2.6 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.68 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$988 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$475 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $25.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...